Stock 3692 HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Hansoh Pharmaceutical Group Company Limited

Equities

3692

KYG549581067

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-06-03 am EDT 		5-day change 1st Jan Change
16.5 HKD +2.74% Intraday chart for Hansoh Pharmaceutical Group Company Limited -2.48% +4.70%
Apr. 29 Hansoh Pharmaceutical Group Company Limited Announces Executive Changes, Effective April 29, 2024 CI
Apr. 03 Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug MT

Evolution of the average Target Price on Hansoh Pharmaceutical Group Company Limited

Price target over the last 5 years

History of analyst recommendation changes

614dbd42a98a81a734b0254df9b6e8.HTeX639r_qeXwbEG87sdf_-83MgJK6GWdhRW9-VQTW4.W3nIoE4mncncudBWrM0vBZuElas4G_LFKVEUnIoEBjF4UsbaTirG5vu36A~17db78d365bae062d29c178d402e301b

Analyst Recommendations on Hansoh Pharmaceutical Group Company Limited

Nomura Downgrades Hansoh Pharmaceutical to Neutral From Buy, Adjusts Price Target to HK$15.03 From HK$13.01 MT
Rising Interest Rates Blunt Asian Stock Markets MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$13.01 From HK$19.49, Keeps at Buy MT
Fitch US Debt Downgrade Undercuts Asian Stock Markets MT
China Economic Prospects, Exchange Rates Churn Asian Stock Markets MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.49 From HK$20.31, Keeps at Buy MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.31 From HK$20.88, Keeps at Buy MT
Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.88 From HK$21.11, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
14.87 CNY
Average target price
17.81 CNY
Spread / Average Target
+19.78%
High Price Target
25.83 CNY
Spread / Highest target
+73.69%
Low Price Target
13.87 CNY
Spread / Lowest Target
-6.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hansoh Pharmaceutical Group Company Limited

Nomura

Ratings for Hansoh Pharmaceutical Group Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 3692 Stock
  4. Consensus Hansoh Pharmaceutical Group Company Limited